Quotient celebrates Alnwick opening

Quotient Sciences held an official ribbon-cutting event to celebrate the opening of its new, £6 million drug substance manufacturing facility in Alnwick, UK, on 9 December. Among those present were Sharon Todd, CEO of the Society of Chemical Industry, and Quotient’s SVP and head of candidate development, Paul Ryan.

The expansion, which was completed in October, features multi-purpose capacity of up to 15 GMP reactor streams with reactor volumes ranging from 5 to 150L, and both batch or continuous flow chemistry technologies. According to Ryan, it was “a necessary step in allowing us to better support our customers’ programmes as they progress through the development pathway”.

About 80-100 new scientific and technical jobs are being created at the site, which has been in existence for 40 years this year. It currently employs 200 people across scientific disciplines including process chemistry, solid-state characterisation, radiosynthesis, bioanalysis and formulation development. Further expansion to meet growing demand is also expected.